Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02317107 · ClinicalTrials.gov registry record

Examination of Balance, Vestibular, and Ocular Functions and Activity Following Concussion

A clinical trial, sponsored by Boston Children's Hospital.

Completed
Registry status
110
Enrollment target

NCT02317107: Completed study, sponsored by Boston Children's Hospital.

NCT02317107 is a clinical trial that has completed, run by Boston Children's Hospital. The registered enrollment target is 110 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02317107 has completed, sponsored by Boston Children's Hospital.

COMPLETED
Registry status
110 participants
Enrollment target

Study Summary

Previous research and position statements have outlined the necessity of balance and gait testing in the post-concussion evaluation of athletes. However, many of the currently available balance testing techniques lack objectivity and sensitivity to the effects of concussion. Such balance impairments may exist following concussion due to disruption of vestibular and/or ocular motor systems. However, no clinically feasible tools have been longitudinally examined to detect gait balance control deficits or to investigate how vestibular or motor dysfunction may lead to gait imbalance. Additionally, participation in physical and cognitive activities post-concussion may affect recovery. While limited evidence exists to support this notion, further investigation is necessary to improve clinical management recommendations. The proposed study will allow for the examination of tools which add value to post-concussion clinical evaluations and study-related outcomes will enhance the understanding of dynamic balance control and vestibular/ocular motor recovery, and their potential for implementation into concussion management protocols.

Primary Outcome

For balance control measures, the primary data will come from accelerometers placed on specific anatomical landmarks to assess whole body movement. Peak accelerations and velocities of an estimated center-of-mass during gait under single-task and dual-task conditions will identify how divided attention tasks affect whole body balance control.

Trial Details

FieldValue
Enrollment Target 110 participants
Start Date 2015-06-30
Est. Completion 2021-01-01
Boston Children's Hospital

462 total trials

What the finished NCT02317107 record still lists

NCT02317107 is an observational study that tracks outcomes without assigning an intervention. The registered 110 participants enrollment target is mid-sized for trials with a published cap.

The record links to 0 conditions, and to 0 interventions.

NCT02317107 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02317107 about?

NCT02317107 is a clinical study titled "Examination of Balance, Vestibular, and Ocular Functions and Activity Following Concussion". Previous research and position statements have outlined the necessity of balance and gait testing in the post-concussion evaluation of athletes. However, many of the currently available balance testing techniques lack objectivity and sensitivity to the effects of concussion. Such balance impairments...

What is the current status of trial NCT02317107?

This trial is currently completed. The enrollment target is 110 participants. The study started on 2015-06-30. Estimated completion is 2021-01-01.

Who is sponsoring clinical trial NCT02317107?

This trial is sponsored by Boston Children's Hospital, which has 462 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01530373 · 110 participants · Phase 2

    Solifenacin Compared to Clonidine for Reducing Hot Flashes Among Breast Cancer Patients

  • NCT02379377 · 110 participants · Phase 1

    18F-FSPG PET in Imaging Patients With Liver Cancer Before Undergoing Surgery or Transplant

  • NCT02411773 · 110 participants · Phase 1

    Sympatholysis in Chronic Kidney Disease

  • NCT03190941 · 110 participants · Phase 1

    Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing the G12V Variant of Mutated RAS in HLA-A*11:01 Patients

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT02317107, the US trial registry maintained by the National Library of Medicine. NCT02317107 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.